On-the-go mindfulness support to quit smoking for cancer survivors
Mindfulness-based ecological momentary intervention for smoking cessation among cancer survivors
This project offers brief mindfulness exercises delivered on smartphones to help cancer survivors stay smoke-free.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11257696 on NIH RePORTER |
What this research studies
As a cancer survivor who smokes or recently quit, you'll receive short mindfulness exercises and real-time prompts on your smartphone when you face cravings or stress. The app asks about cancer-related symptoms like pain, fatigue, and fear of recurrence and offers breathing and awareness practices tailored to those moments. Researchers will collect brief in-the-moment survey responses and app usage data to personalize support and learn which strategies reduce relapse. The program is designed to be shorter and more accessible than traditional in-person mindfulness programs.
Who could benefit from this research
Good fit: Ideal candidates are cancer survivors who currently smoke or recently quit and have a smartphone and willingness to try app-based mindfulness support.
Not a fit: People without a smartphone, those who prefer only in-person therapy, or individuals with severe cognitive or sensory impairments may not benefit from the app-based approach.
Why it matters
Potential benefit: If successful, this could help cancer survivors reduce relapse and maintain long-term smoking abstinence with convenient, on-demand support.
How similar studies have performed: Mindfulness and mobile health approaches have helped some smokers in prior work, but combining real-time, cancer-specific mindfulness support on smartphones is relatively new.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Yang, Min-Jeong — Rutgers Biomedical and Health Sciences
- Study coordinator: Yang, Min-Jeong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.